A novel means of modeling sporadic amyotrophic lateral sclerosis (SALS) using motor neurons derived from induced pluripotent stem (iPS) cells should provide new insights into the pathology of the disease, researchers reported in the Aug. 20, 2018, edition of Nature Medicine.